| 1 | 17466968 | The Mi-2 nucleosome-remodeling protein LET-418 is targeted via LIN-1/ETS to the promoter of lin-39/Hox during vulval development in C. elegans. | Dev Biol | 2007 Jun 15 |
2 |
| 2 | 26728103 | Short Communication: Preferential Killing of HIV Latently Infected CD4(+) T Cells by MALT1 Inhibitor. | AIDS Res Hum Retroviruses | 2016 Feb |
1 |
| 3 | 28928392 | Mucosa-associated lymphoid tissue lymphoma translocation 1 as a novel therapeutic target for rheumatoid arthritis. | Sci Rep | 2017 Sep 19 |
2 |
| 4 | 28993409 | MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. | Cancer Res | 2017 Dec 15 |
1 |
| 5 | 30249750 | Treatment of Dextran Sulfate Sodium-Induced Colitis with Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Inhibitor MI-2 Is Associated with Restoration of Gut Immune Function and the Microbiota. | Infect Immun | 2018 Dec |
5 |
| 6 | 30284489 | Wide-range effects of the MALT-1 inhibitor Mi-2 in CLL cells results in apoptosis. | Leuk Lymphoma | 2019 Mar |
1 |
| 7 | 31226128 | DREF Genetically Counteracts Mi-2 and Caf1 to Regulate Adult Stem Cell Maintenance. | PLoS Genet | 2019 Jun |
1 |
| 8 | 35309901 | Targeting MALT1 Suppresses the Malignant Progression of Colorectal Cancer <i>via</i> miR-375/miR-365a-3p/NF-κB Axis. | Front Cell Dev Biol | 2022 |
1 |